VRCA

Verrica Pharmaceuticals (VRCA)

About Verrica Pharmaceuticals (VRCA)

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Details

Daily high

$0.66

Daily low

$0.56

Price at open

$0.60

52 Week High

$11.41

52 Week Low

$0.51

Market cap

51.2M

Dividend yield

0.00%

Volume

1,420

Avg. volume

500,689

P/E ratio

-.36

Verrica Pharmaceuticals News